Intrinsic Value of S&P & Nasdaq Contact Us

Rapid Therapeutic Science Laboratories, Inc. RTSL OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
16/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — RTSL

Rapid Therapeutic Science Laboratories, Inc. (RTSL) has a market capitalization of $52.99K and trades at $0.01. The 52-week range is 0.001-0.008.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-0.01.

The stock has a beta of -1.80, operates in the Healthcare sector.

Trading Data
Current Price$0.01
52-Week Range0.001-0.008
Volume9.5K
Avg Volume (30D)4.6K
Market Cap$52.99K
Beta (1Y)-1.80
Company
IPO Date2017-06-14
Employees3
CEODonal R. Schmidt Jr.
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS7534312043
CUSIP753431105
Income (Latest Year)
Gross Profit$-23.97K
EBITDA$-59.25K
Operating Income$-83.23K
Net Income$-183.3K
EPS$-0.01
EPS Diluted$-0.01
Shares Outstanding$19.3M
Balance Sheet (Latest Year)
Total Assets$967.76K
Current Assets$175.05K
Total Liabilities$4.05M
Total Debt$3.45M
Net Debt$3.45M
Total Equity$-3.08M
Debt / Equity-1.12
Valuation Ratios
P/E Ratio-0.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message